MarkLWarrenMD

Endocrinology • Greenville, NC

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Warren is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Warren's full profile

Already have an account?

Office
1006 WH Smith Blvd
Greenville, NC 27834
Phone+1 252-752-6101

Fax+1 252-752-6600

Education & Training

University of Virginia Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1989
University of Virginia Medical CenterResidency, Internal Medicine, 1984 - 1989
University of North Carolina at Chapel Hill School of MedicineClass of 1984

Certifications & Licensure

NC State Medical License 1989 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting Start of enrollment: 2012 Jan 01
Completed
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
Completed
Phase 3
A Registry for Participants With Chronic Hypoparathyroidism Start of enrollment: 2013 Jul 30
Active, not recruiting
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
A Scalable Application of Artificial Intelligence-Driven Insulin Titration Program to Transform Type 2 Diabetes Management.
Mark Warren, Richard M Bergenstal, Matthew Hager, Eran Bashan, Israel Hodish
Diabetes Technology & Therapeutics. 2024-08-01
2 citations
Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.
Nelson B Watts, John P Bilezikian, Henry G Bone, Bart L Clarke, Douglas Denham
Journal of the Endocrine Society. 2023-03-06
21 citations
Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2
Mark Warren, Bruce W. Bode, Jang Ik Cho, Rong Liu, Janet Tobian
Diabetes, Obesity & Metabolism. 2021-07-01

Press Mentions

Hygieia Adds Clinical Partners to Expand Digital Insulin Management ProgramSeptember 12th, 2022
Veritas Collaborative Expands Adult Inpatient and Residential Programming in Durham, NCJanuary 20th, 2024